Asia- Pacific Plasma Fractionation Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Published Report
  • Jul 2021
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 125
  • No of Figures: 43

By product type (immunoglobulins, coagulation factor concentrate, albumin, protease inhibitors and other products.), application (neurology, immunology, hematology, critical care, pulmonology, hemato- oncology, rheumatology and others),  processing technology (Ion- exchange chromatography , affinity chromatography, cryopreservation, ultrafiltration and microfiltration), mode(modern plasma fraction and traditional plasma fractionation), End user (Hospitals & clinics, clinical research laboratories academic institutions and others), Distribution channel (into direct tenders, third party distribution and others) ,  Countries(China, Japan, South Korea, Australia, India, Malaysia, Thailand, Singapore and rest of Asia Pacific ) Industry Trends and Forecast to 2028.

Asia- Pacific Plasma Fractionation Market Market Analysis and Insights: Asia- Pacific Plasma Fractionation Market

Asia- Pacific Plasma Fractionation Market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.5%in the forecast period of 2021 to 2028 and is expected to reach USD 7,111.80 Million by 2028.

Plasma is a blood component, derives from whole blood by plasmapheresis and used for various therapeutic and medical applications. Human plasma is s source of numerous different proteins, however only a few of these proteins are useful for producing therapeutic plasma products . the process of separation, extraction, and purification of these proteins from the plasma is called fractionation process. The proteins extracted from the plasma are mainly categorized into classes such as immunoglobulins , coagulation factor concentrates, albumin , protease inhibitors, and others

Asia- Pacific plasma Fractionation market is growing with factors such as rise in respiratory diseases across the world, increase in aging population with blood-related ailments, and increasing usage of immunoglobulins. Increase in rare diseases that require the use of plasma therapy or plasma derivatives also acts as a major factor for the growth of the market. Increasing investment in research and development has also given a boom to the Asia- Pacific plasma fractionation market.

This Plasma Fractionation market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Asia- Pacific Plasma Fractionation Market Asia- Pacific Plasma Fractionation  Market Scope and Market Size

Asia- Pacific Plasma Fractionation Market, By product type (immunoglobulins, coagulation factor concentrate, albumin, protease inhibitors and other products.), application (neurology, immunology, hematology, critical care, pulmonology, hemato- oncology, rheumatology, and others),  processing technology (Ion- exchange chromatography , affinity chromatography, cryopreservation, ultrafiltration, and microfiltration), mode(modern plasma fraction and traditional plasma fractionation), End user (Hospitals & clinics, clinical research laboratories academic institutions and others), Distribution channel (into direct tenders, third party distribution, and others). The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets. On the basis of product type, the plasma fractionation market is segmented into immunoglobulins, coagulation factor concentrate, albumin, protease inhibitors, and other products. Further, the  Immunoglobulins have been segmented further into intravenous immunoglobulins, subcutaneous immunoglonbulins, and others. Coagulation factor concentrates are further subsegmented into factor VIII, Factor CI, Von willebrand factor, Prothrombin complex concentrate, fibrinogen concentrates, and factor XII. In 2021, immunoglobulin has the largest market share owing to the factors such as the high number of health benefits associated with immunomodulatory actions.

  • On the basis of application, the plasma fractionation market is segmented into neurology, immunology, hematology, critical care, pulmonology, hemato- oncology, rheumatology and others. In 2021,  Immunology  has the largest market share owing to the factors such as increasing usage of plasma proteins in the treatment of immune deficiencies.
  • On the basis of processing technology , the plasma fractionation market is segmented into Ion- exchange chromatography , affinity chromatography, cryopreservation, ultrafiltration and microfiltration. In 2021, Ion- exchange chromatography  has the largest market share owing to the factor such as the high purification capability using ions by removing inorganic substances.
  • On the basis of mode, the plasma fractionation market is segmented into modern plasma fraction and traditional plasma fractionation. In 2021, modern plasma fractions has the largest market share owing to the factors such as the employing the state of art equipment and production facilities for the plasma fractionation process.
  • On the basis of End User, the plasma fractionation market is segmented into Hospitals & clinics, clinical research laboratories academic institutions and others. In 2021, hospitals & clinics  has the largest market share due to improving infrastructure and health care facilities provided by hospitals, along with increasing off- label use of plasma fractionated products in hospitals to treat various diseases..
  • On the basis of Distribution channel, the plasma fractionation market is segmented into direct tenders, third party distribution and others . In 2021, direct tenders has the largest market share due to. Increasing distribution through direct tenders from the manufacturers to the health care workers.

Asia- Pacific Plasma Fractionation Market: Country Level Analysis

Asia- Pacific Plasma Fractionation  Market is analysed and market size information is provided by country, Type (Bioinsecticides, Biofungisides, Bionematicides, Bioherbicides and Others), Source (Microbials, Biochemical and Insects), Form (Dry and Liquid), Application (Foliar Application, Fertigation, Soil Treatment, Seed Treatment and Other), Category (Agriculture and Horticulture) and Crops as referenced above.

The countries covered in the Asia- Pacific Plasma Fractionation Market report are China, Japan, South Korea, Australia, India, Malaysia, and others

China is dominating in the Asia- Pacific Plasma Fractionation Market with the highest CAGR as the region has more awareness about the extensive benefits of the plasma.

Japan is dominating in the Asia- Pacific Plasma Fractionation market due to increase in the demand for Plasma Fractionation and growing concern over the human health.

South Korea is dominating the market with the highest share due to the geriatric population and immune deficiency diseases.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia- Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Rising Demand of Plasma Fractionation in Agriculture

Asia- Pacific Plasma Fractionation Market also provides you with detailed market analysis for every country growth in the industry with sales, components sales, impact of technological development in Plasma Fractionation, and changes in regulatory scenarios with their support for the Plasma Fractionation Product market. The data is available for historic period 2012-2018.

Competitive Landscape and Asia- Pacific Plasma Fractionation Market Share Analysis

Asia- Pacific Plasma Fractionation Market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, India presence, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Asia- Pacific Plasma Fractionation Market.

Some of the major players operating in the plasma fractionation market are SL plasma, Grifols S.A., Octapharma, Kendrion S.P.A, BPL Inc, Sanquin, Biotest AG, LFB S.A., Japan Blood products organization, china biologics product Holdings Inc.,, Green Cross corp, Shanghai Raas, Takeda pharmaceutical company limited, Bioproducts laboratory Ltd, Novasep Inc, Pall corporation, Kabafusion , Sichuan Yuanda shuyang pharmaceutical Co., ltd, Bharat serums and vaccines limited, SK plasma, Centurion pharma, Ntas biopharmaceuticals , Merck KgAa, Boccard and ADMA biologics.

Many product launches are also initiated by the companies worldwide which are also accelerating the growth of Asia- Pacific Plasma Fractionation  Market.

For instance,

  • In April 2020, Grifols launched 3- ml vial for Hyper RAB which is rabies immune globulin in the plasma fractionation market to help in the treatment of rabies cases across the world.

Collaboration, joint ventures and other strategies by the market players is enhancing the company footprints in the Plasma Fractionation market which also provides the benefit for organisation in its growth pace.

Customization Available: Asia- Pacific Plasma Fractionation Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

TABLE 1 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 2 ASIA-PACIFIC IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 3 ASIA-PACIFIC IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 4 ASIA-PACIFIC COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 5 ASIA-PACIFIC COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 6 ASIA-PACIFIC ALBUMIN IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 7 ASIA-PACIFIC PROTEASE INHIBITORS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 8 ASIA-PACIFIC OTHER PRODUCTS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 9 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, APPLICATION, 2019-2028 (USD MILLION)

TABLE 10 ASIA-PACIFIC IMMUNOLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 11 ASIA-PACIFIC HAEMATOLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 12 ASIA-PACIFIC CRITICAL CARE IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 13 ASIA-PACIFIC NEUROLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 14 ASIA-PACIFIC PULMONOLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 15 ASIA-PACIFIC HAEMATO-ONCOLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 16 ASIA-PACIFIC RHEUMATOLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 ASIA-PACIFIC OTHER APPLICATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 19 ASIA-PACIFIC ION-EXCHANGE CHROMATOGRAPHY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 ASIA-PACIFIC AFFINITY CHROMATOGRAPHY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 ASIA-PACIFIC ULTRAFILTRATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 ASIA-PACIFIC MICROFILTRATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 ASIA-PACIFIC CRYOPRECIPITATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, MODE, 2019-2028 (USD MILLION)

TABLE 25 ASIA-PACIFIC MODERN PLASMA FRACTIONATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 ASIA-PACIFIC TRADITIONAL PLASMA FRACTIONATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, END USER, 2019-2028 (USD MILLION)

TABLE 28 ASIA-PACIFIC HOSPITALS & CLINICS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 ASIA-PACIFIC CLINICAL RESEARCH LABORATORIES IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 30 ASIA-PACIFIC ACADEMIC INSTITUTES IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 31 ASIA-PACIFIC OTHERS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 33 ASIA-PACIFIC DIRECT TENDERS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 34 ASIA-PACIFIC THIRD PARTY DISTRIBUTION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 35 ASIA-PACIFIC OTHERS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 36 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 37 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 38 ASIA-PACIFIC IMMUNOGLOBINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 39 ASIA-PACIFIC COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 40 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 41 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 42 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 43 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 44 ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 45 CHINA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 46 CHINA IMMUNOGLOBINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 47 CHINA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 48 CHINA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 49 CHINA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 50 CHINA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 51 CHINA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 52 CHINA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 53 JAPAN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 54 JAPAN IMMUNOGLOBINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 55 JAPAN COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 56 JAPAN PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 57 JAPAN PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 58 JAPAN PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 59 JAPAN PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 60 JAPAN PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 61 SOUTH KOREA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 62 SOUTH KOREA IMMUNOGLOBINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 63 SOUTH KOREA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 64 SOUTH KOREA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 65 SOUTH KOREA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 66 SOUTH KOREA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 67 SOUTH KOREA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 68 SOUTH KOREA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 69 AUSTRALIA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 70 AUSTRALIA IMMUNOGLOBINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 71 AUSTRALIA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 72 AUSTRALIA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 73 AUSTRALIA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 74 AUSTRALIA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 75 AUSTRALIA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 76 AUSTRALIA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 77 INDIA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 78 INDIA IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 79 INDIA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 80 INDIA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 81 INDIA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 82 INDIA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 83 INDIA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 84 INDIA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 85 MALAYSIA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 86 MALAYSIA IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 87 MALAYSIA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 88 MALAYSIA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 89 MALAYSIA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 90 MALAYSIA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 91 MALAYSIA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 92 MALAYSIA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 93 THAILAND PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 94 THAILAND IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 95 THAILAND COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 96 THAILAND PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 97 THAILAND PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 98 THAILAND PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 99 THAILAND PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 100 THAILAND PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 101 SINGAPORE PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 102 SINGAPORE IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 103 SINGAPORE COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 104 SINGAPORE PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 105 SINGAPORE PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 106 SINGAPORE PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 107 SINGAPORE PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 108 SINGAPORE PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 109 PHILIPPINES PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 110 PHILIPPINES IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 111 PHILIPPINES COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 112 PHILIPPINES PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 113 PHILIPPINES PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 114 PHILIPPINES PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 115 PHILIPPINES PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 116 PHILIPPINES PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 117 INDONESIA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 118 INDONESIA IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 119 INDONESIA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

TABLE 120 INDONESIA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 121 INDONESIA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 122 INDONESIA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)

TABLE 123 INDONESIA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 124 INDONESIA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 125 REST OF ASIA-PACIFIC PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions